RetroChimera: New research advances AI-assisted molecule synthesis

Microsoft Research and partners including GSK and Novartis have developed RetroChimera, an AI model that automates retrosynthesis, proposing promising synthetic routes for molecules with performance closely aligned to expert chemists' expectations. The model can be adapted to proprietary chemistry data, enabling practical applications in drug discovery and materials science beyond academic benchmarks.

This Wire brief sits within Fusion42's coverage of Biotech.